Matches in Wikidata for { <http://www.wikidata.org/entity/Q70201689> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q70201689 description "article scientifique publié en 1981" @default.
- Q70201689 description "artículu científicu espublizáu n'avientu de 1981" @default.
- Q70201689 description "im Dezember 1981 veröffentlichter wissenschaftlicher Artikel" @default.
- Q70201689 description "scientific article published on 01 December 1981" @default.
- Q70201689 description "wetenschappelijk artikel" @default.
- Q70201689 description "наукова стаття, опублікована в грудні 1981" @default.
- Q70201689 name "The antihypertensive effects of ketanserin (R 41468), a novel 5-hydroxytryptamine-blocking agent, in patients with essential hypertension" @default.
- Q70201689 name "The antihypertensive effects of ketanserin (R 41468), a novel 5-hydroxytryptamine-blocking agent, in patients with essential hypertension" @default.
- Q70201689 type Item @default.
- Q70201689 label "The antihypertensive effects of ketanserin (R 41468), a novel 5-hydroxytryptamine-blocking agent, in patients with essential hypertension" @default.
- Q70201689 label "The antihypertensive effects of ketanserin (R 41468), a novel 5-hydroxytryptamine-blocking agent, in patients with essential hypertension" @default.
- Q70201689 prefLabel "The antihypertensive effects of ketanserin (R 41468), a novel 5-hydroxytryptamine-blocking agent, in patients with essential hypertension" @default.
- Q70201689 prefLabel "The antihypertensive effects of ketanserin (R 41468), a novel 5-hydroxytryptamine-blocking agent, in patients with essential hypertension" @default.
- Q70201689 P1433 Q70201689-329E7404-DD64-480E-AD6E-9959A946802E @default.
- Q70201689 P1476 Q70201689-4A1D408E-F99A-4E47-8D52-42BD235FE2C0 @default.
- Q70201689 P2093 Q70201689-6AC2DBA1-3C65-466B-91A1-7C31D40CF8A6 @default.
- Q70201689 P2093 Q70201689-7C8DB89C-C191-4958-BBCF-C7A8521C8712 @default.
- Q70201689 P2093 Q70201689-9009DB88-04AD-4EA0-B5EE-70E72A7762B2 @default.
- Q70201689 P2093 Q70201689-A454A56C-1036-4AF9-84E0-ED2876602CE2 @default.
- Q70201689 P2093 Q70201689-FE3F6490-C8F3-4529-A257-E643D0927C86 @default.
- Q70201689 P304 Q70201689-65E9FF33-B985-4F33-8F70-3B5ED9089C1F @default.
- Q70201689 P31 Q70201689-4AE1D14E-B705-422B-84FA-4018AABDC498 @default.
- Q70201689 P356 Q70201689-5726CC40-5CC3-46EE-A59C-15799C471A1D @default.
- Q70201689 P478 Q70201689-74CBB925-BFBC-462F-B4CD-F2485C0C2A46 @default.
- Q70201689 P577 Q70201689-985B5437-2643-42BA-AC4D-AFC928C382B9 @default.
- Q70201689 P698 Q70201689-5D5B7F15-9DA4-4633-BC8A-77D48D0DBC5C @default.
- Q70201689 P921 Q70201689-8E877941-E0A3-4FB2-BEB4-D6A7A6A0F80A @default.
- Q70201689 P356 CS061473S @default.
- Q70201689 P698 7032829 @default.
- Q70201689 P1433 Q372419 @default.
- Q70201689 P1476 "The antihypertensive effects of ketanserin (R 41468), a novel 5-hydroxytryptamine-blocking agent, in patients with essential hypertension" @default.
- Q70201689 P2093 "H Geukens" @default.
- Q70201689 P2093 "H Verhaegen" @default.
- Q70201689 P2093 "J De Crée" @default.
- Q70201689 P2093 "J Leempoels" @default.
- Q70201689 P2093 "W De Cock" @default.
- Q70201689 P304 "473s-476s" @default.
- Q70201689 P31 Q13442814 @default.
- Q70201689 P356 "10.1042/CS061473S" @default.
- Q70201689 P478 "61 Suppl 7" @default.
- Q70201689 P577 "1981-12-01T00:00:00Z" @default.
- Q70201689 P698 "7032829" @default.
- Q70201689 P921 Q988405 @default.